and quite unselected. The total number of cases under review is, therefore, 434. Patients who exhibited an intolerance of tryparsamide, and for whom the course, therefore, had to be discontinued, are also excluded from the series. In all cases in each series the results of examination of the cerebrospinal fluid were strongly positive: Wassermann plus, increased cells and protein and paretic Lange curve. The clinical diagnosis is recorded in Table 1 . With rare exceptions each patient had a course of malaria from one species only. The species employed were benign tertian, quartan, malignant tertian and infection caused by Plasmodium ovale; P. knowlesi (monkey malaria) was used for three patients.. The average number of peaks of fever aimed at was 10, although this was not possible of attainment in every case. Temperatures of 1030 F. and over were counted as peaks of fever. To some of the patients receiving quartan malaria infection, tryparsamide was given during the fever.
Patients have been followed up after discharge as far as possible, although the evacuation of population and the war damage sustained in London have made this difficult. In spite of these drawbacks, however, a large proportion of ex-patients have been in contact with us over periods of 10-12 years.
Clinical results
The clinical results obtained are shown in Table 2 . Among the discharged patients a total of 11 are known to have died ; of these 3 were in the malaria and 8 in the malaria-plus-tryparsamide group. All those ex-patients died of intercurrent disease ; indeed, 2 men in the tryparsamide series were killed in the recent war (one in the Royal Air Force and the other in the National Fire Service during the "blitz") and one man (malaria only) was a fatal air-raid casualty. Admittedly, some of the patients retained in hospital died group who have had tests since treatment have been followed up for a longer period. We have been impressed with a recent paper by Dattner, Thomas and Wexler2 and a subsequent letter by Thomas, in which the authors stress the need for rapid treatment and for the complete cessation of any further therapy if, 6 months after malaria treatment plus chemotherapy, the cerebrospinal fluid has DISEASES~aa.u -The present state of our knowledge regarding cerebrospinal fluid examinations comprises 170 cases in the first series and 203 cases in the second series. Table 3 shows the position, It is a matter for regret that we are not in a position to give more accurate information about the first series, but we feel justified in drawing certain conclusions in all cases of patients who have been followed up and who are out of hospital and well 3 years or more after treatment; this applies to cases with positive reactions in which the fluid was not re-tested after 6 months and to cases which were never tested. The number of cases in the first series is 72 and in the second series 68.
Among the malaria-treated cases are 20 patients who made good recoveries and whom we followed up for periods of 3-12 years; their reactions are almost certainly negative; 45 have died within 3 years of treatment and it is assumed that the fluids were still positive at death; 3 have never been followed up. Applying similar tests to the first series, the reactions in 30 cases are negative; in 25 they remain positive; 3 patients discharged in an unsatisfactory condition were lost sight of and their reactions are included in the positive group; 14 other discharged patients were not followed up. This revised estimate is shown in Fig. 3 , the7hatched areas representing the adjusted figures.
A further analysis was made (see Table 4 ) in which are recorded the examinations made at the end of 6 months and then each subsequent year. It will be noted that We know that many patients with a positively reacting fluid died within a year of treatment; but what happens to those patients who. survive and whose fluid -reacts positively at the end of 2 years ? Of 13 such cases in the first series and 30 in the second, 7 and 20 patients subsequently died. Of the 10 patients remaining alive in the malaria-treated series, 6 were re-treated with a second course of malaria; in all except one a negatively reacting fluid developed; in the exception the reactions remained positive and the patient died soon after the second course; the other 4 patients received no further treatment, and in 2 cases inactive reactions developed, but the reactions in the other 2 became negative. In the tryparsamide series, in the 6 patients who survived, the reactions in all cases eventually became completely negative without further treatment. It is, however, a very small percentage of patients, who, if deprived of further treatment, survive to behave in this manner and become spontaneously negative. On the other hand, it is rare to find cases resistant to additional therapy; but such cases do. occur, as is illustrated by the following example.
F.H. (M.389), aged 46 years, suffering from general paralysis, was given benign tertian fever, 7 peaks. The cerebrospinal fluid was examined at six-monthly intervals and remained persistently positive. At the end of 2 years he had a course of malignant tertian, 10 peaks. At the end of 4 years there was no change whatever in the serological reactions, so quartan was then administered, 7 peaks. It was not until 3 years later that the fluid became inactive and the last test at the end of 1944 was negative. This man has been out of hospital since the first course of therapy in 1938 and is now working in a factory.
The occurrence of serological relapses in the two series is very small: 2 in the malaria group and 3 in the other series. Of these relapsed cases, 4 patients had a single negative result, all showing strongly positive reactions a year later; the fifth case had an inactive fluid, which reverted to positive, but after further treatment became inactive again. In no patient who had 2 consecutive negative results did any serological relapse occur, as recorded by subsequent tests.
Toxic manifestations
Brief mention must be made of the toxic reactions which occur in tryparsamide therapy and which give rise to considerable alarm. In our series, of 10 patients who began to receive a course of tryparsamide, one exhibited nitritoid reactions, one had jaundice, and 8 had misty vision, 2 being blind for several days. (The visual fields were not examined.) In all cases toxicity was detected bqfore 3 injectionshad been given and the medicament was discontinued immediately. None of these cases has been included in the series discussed, so the incidence of toxicity is 10 cases out of 227, or about 4 per cent.
The incidence is very much lower than that reported by Downs, McDermott and Webster, who report visual reactions in 93 cases out of a series of 223 ; of these 41 were subjective, but contraction of the visual field was demonstrable in the other 52. Kopp and Solbmon 2 report a much larger series (829 patients); in 4-5 per cent of their cases visual disturbances developed half the number of patients so affected had symptoms during the first 5 injections.
Discussion
On examination of both clinical and serQlogical results, it is seen that patients treated with malaria plus tryparsamide do better than do those given malaria only. Although in both series the fluid becomes negative in a large proportionof those who survive, the fact remains that the death rate is higher in the malaria series, and that the cerebrospinal fluid reactions are apt to remain positive. longer than if the patient had had a subsequent course of chemotherapy.
Solomon and Epstein reviewed-a series of 173 patients treated with malaria, plus some form of chemotherapy, chiefly tryparsamide. Completely negative fluid reactions were found in 36-7 per cent of patients followed up for 3-9 years after treatment. (In our series of malaria plus tryparsamide, 52 per cent of the patients had a completely negative reaction at the end of 3 years.) These authors do not state how much malaria was given, but the post-malarial treatment was in nearly every case longer than that given at Horton.
O'Leary and his collaborators report, at the end of 3 years, only 5-8 per cent of negative cerebrospinal fluid reactions in cases treated with malaria alone, compared with 30 per cent in our series; in fact, in their cases treated with malaria plus chemotherapy, not more than 29x6 per cent are recorded as having negative reactions.
Marsh is of the opinion that tryparsamide therapy alone yields results inferior to those obtained by the use of malaria,, but "its use in conjunction with malaria or other forms of artificially induced fever, seems to enhance the beneficial effects of both. Also, the unfortunate patient who is considered to be too poor a rigk for some form of fever therapy, can usually be offered tryparsamide with at least a hope of benefit." The course of tryparsamide (22 grammes) given to our patients is smaff compared with that given in other clinics. Hinrichsen, in a review of the literature dealing with tryparsamide therapy in the treatment of syphilis, refers to the frequent necessity for giving more than 50 injections of the compound in order to produce the desired changes in the cerpbrospinal fluid; this entails treatment being spread over 2-3 years.
This brings us to a very important point, and that is the duration of treatment. Dattner, Thomas and Wexler2 give malaria plus 10 days' Mapharsen (0.06 gramme daily) immediately after the last fever session; they evidently prefer Mapharsen to tryparsamide. No further treatment is permitted; the queWtion of re-treatment,' if necessary, is reviewed at the end of 6 months, when the first post-treatment lumbar puncture is performed. We are in agreement with this procedure, as there is, no doubt, a great risk of overtreating patients. If, as Dattner, Thomas and Wexler' state, the whole treatment can be completed in' hospital, much expense in further treatment is eliminated; moreover, one avoids "the inevitable delinquencies which occur during weekly routine injections". As Goldman experimented with intrathecal injections of penicillin. Neymann, Heilbrunn and
Youmans draw attention to the danger of administering penicillin by the intracisternal route, ; but their paper refers to 5 cases only. Gammon and his co-workers give their experience in treating 89 cases with penicillin only ; they found that, to observe the full effect, serological tests should be followed up for at least 120 days. They devised a plan of giving penicillin in 2 courses: a single course to be followed by the second course which is split into two parts, one given at the end of the first course and the other about 120 days later. Rose and his co-workers find penicillin rather more attractive as an adjuvant to malaria or fever therapy ; by the use of it the amount of fever therapy can be cut down to one half the total which formerly would have been considered to be necessary. In a more recent communication, O'Leary, Brunsting and Ockerley report their trials with intramuscular, intravenous and intrathecal routes of penicillin administration to 100 patients; penicillin treatment was combined with hyperthermia or malaria, and the clinical results, although good, were not superior to those obtained by pyrexial treatment alone.
In Great Britain no reports have been published, but cases of general paralysis have been treated with penicillin at a naval auxiliary hospital and a military centre. I have been able to see the work at the naval hospital, where penicillin alone was being used, and it is hoped that the results will be published. The question of dosage, the length of treatment and the method have yet to be standardized, but even if penicillin does not fulfil all expectations, the advantage of combining it with malaria, by means of which combination the amount of pyrexial treatment c can be diminished, will make malaria therapy a much easier procedure than hitherto and one giving less cause for anxiety. Summary and conclusions
(1) In the treatment of general paralysis and taboparesis, decidedly better clinical and serological results were obtained in the cases treated with both malaria and tryparsamide than in those treated with malaria alone.
(2) The number of cases under review is equal in each series: 127 men and 90 women.
(3) The serological results are discussed in relation to diagnosis and to the sex of the patients.
The results of malaria therapy in the treatment of neurosyphilis are assessable from two aspects, clinical and serological. From the point of view of the patient, of his relatives and of the community, the former is obviously the more useful and for a long time it was, and sometimes it still is, the only thing considered. This outlook was inevitable until some sort of working hypothesis could be produced to explain the action of malaria.
It is now more or less generally accepted that malaria is a spirochaeticidal agent and that its success in neurosyphilis is due to its action in bringing about the death of the spirochaetes. In order to assess the success or failure of the treatment we need some indicator of the presence of the living organism. This has been found in the cerebrospinal fluid. A positive reaction of the cerebrospinal fluid indicates the presence of living spirochaetes, a negative one of dead organisms. We 
